Switch to:

Beam Therapeutics EV-to-Revenue

: 52,583.29 (As of Today)
View and export this data going back to 2020. Start your Free Trial

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Beam Therapeutics's enterprise value is $1,262.00 Mil. Beam Therapeutics's Revenue for the trailing twelve months (TTM) ended in Mar. 2020 was $0.02 Mil. Therefore, Beam Therapeutics's EV-to-Revenue for today is 52,583.29.

NAS:BEAM' s EV-to-Revenue Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: 52583.29

NAS:BEAM's EV-to-Revenue is ranked lower than
99.99% of the 836 Companies
in the Biotechnology industry.

( Industry Median: 17.68 vs. NAS:BEAM: 52583.29 )

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2020-07-02), Beam Therapeutics's stock price is $29.01. Beam Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2020 was $0.00. Therefore, Beam Therapeutics's PS Ratio for today is .


Beam Therapeutics EV-to-Revenue Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Beam Therapeutics Annual Data
Dec17 Dec18 Dec19
EV-to-Revenue 0.00 0.00 0.00

Beam Therapeutics Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
EV-to-Revenue Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 13,973.29

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Beam Therapeutics EV-to-Revenue Distribution

* The bar in red indicates where Beam Therapeutics's EV-to-Revenue falls into.



Beam Therapeutics EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Beam Therapeutics's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1261.999/0.024
=52,583.29

Beam Therapeutics's current Enterprise Value is $1,262.00 Mil.
Beam Therapeutics's Revenue for the trailing twelve months (TTM) ended in Mar. 2020 was 0.006 (Jun. 2019 ) + 0.006 (Sep. 2019 ) + 0.006 (Dec. 2019 ) + 0.006 (Mar. 2020 ) = $0.02 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Beam Therapeutics  (NAS:BEAM) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Beam Therapeutics's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=29.01/0
=

Beam Therapeutics's share price for today is $29.01.
Beam Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2020 was 0 (Jun. 2019 ) + 0 (Sep. 2019 ) + 0 (Dec. 2019 ) + 0 (Mar. 2020 ) = $0.00.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Beam Therapeutics EV-to-Revenue Related Terms


Beam Therapeutics EV-to-Revenue Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)